Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo

John Davis Groopman, W. F. Busby, G. N. Wogan

Research output: Contribution to journalArticle

Abstract

The distribution and retention of [3H]aflatoxin B1 (AFB1) residues in rat liver nuclear fractions were determined at 0.5, 2, 12, and 36 hr following administration of a single i.p. dose of [3H]AFB1 (1 mg/kg body weight). Approximately 85 to 90% of the nuclear-bound AFB1 was associated with chromatin 2 hr after aflatoxin treatment, with the remainder present in the nucleoplasmic fraction. Further fractionation of the chromatin showed that approximately 80% of the aflatoxin residues was bound to the DNA, 10% was removed by dialysis, and the remaining 10% was recoverable in the dialyzed chromatin protein fraction. The apparent rate of removal of aflatoxin residues from DNA was twice as fast (t 1/2 = 12 hr) as that from the chromatin proteins (t 1/2 = 24 hr). Liver nucleoplasmic and chromatin proteins were separated by sodium dodecyl sulfate:polyacrylamide gel electrophoresis. No major differences were observed in the Coomassie Blue dye-binding patterns of control and AFB1-treated animals for at least 36 hr postdosing. Although no significant radiolabeled protein peaks were detected in the nucleoplasmic fraction, two major peaks, accounting for 50 to 60% of the total activity applied to the gel, were observed at each time point in the chromatin protein fraction, with apparent molecular weights of 15,000 and 30,000. Approximately 5 to 10% of the total nuclear-bound aflatoxin residues were associated with these proteins, which were identified as histones by their extraction in 0.25 N HCl and their fractionation patterns on polyacrylamide gel filtration columns and acid:urea gel electrophoresis. Specific activity measurements demonstrated that histone H1 was the major protein target for [3H]AFB1 residue binding with an adduction level 3 to 4 times higher than that for any other histone. A linear, dose-dependent relationship for the binding of [3H]AFB1 residues to DNA, histone H1, and the total histone population was noted over a 16-fold dose range (0.125 to 2.0 mg AFB1 per kg). Turnover rates of rat liver histones as a function of AFB1 exposure were determined by labeling the amino acids of histones by i.p. injection of sodium [14C]bicarbonate 22 hr prior to treatment with the toxin and sacrificing the animals up to 4 days following the dosage protocol. The half-life of histone H1 and the total histone population was identical (approximately 3.5 days) in both control and AFB1-treated rats. However, the rate of removal of [3H]AFB1 residues following either a 0.125- or a 1.0-mg/kg dose was 3 to 4 times faster (t 1/2 = approximately 1 day) than was the decrease in specific activity of the 14C-labeled histone backbone.

Original languageEnglish (US)
Pages (from-to)4343-4351
Number of pages9
JournalCancer Research
Volume40
Issue number12
StatePublished - 1980
Externally publishedYes

Fingerprint

Aflatoxin B1
Histones
Liver
Chromatin
Aflatoxins
Proteins
DNA
Gels
Sodium Bicarbonate
Sodium Dodecyl Sulfate
Population
Gel Chromatography
Half-Life
Urea
Electrophoresis
Polyacrylamide Gel Electrophoresis
Dialysis
Coloring Agents
Molecular Weight
Body Weight

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. / Groopman, John Davis; Busby, W. F.; Wogan, G. N.

In: Cancer Research, Vol. 40, No. 12, 1980, p. 4343-4351.

Research output: Contribution to journalArticle

@article{c7f1361c6b724449a651e1d08a9b5f52,
title = "Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo",
abstract = "The distribution and retention of [3H]aflatoxin B1 (AFB1) residues in rat liver nuclear fractions were determined at 0.5, 2, 12, and 36 hr following administration of a single i.p. dose of [3H]AFB1 (1 mg/kg body weight). Approximately 85 to 90{\%} of the nuclear-bound AFB1 was associated with chromatin 2 hr after aflatoxin treatment, with the remainder present in the nucleoplasmic fraction. Further fractionation of the chromatin showed that approximately 80{\%} of the aflatoxin residues was bound to the DNA, 10{\%} was removed by dialysis, and the remaining 10{\%} was recoverable in the dialyzed chromatin protein fraction. The apparent rate of removal of aflatoxin residues from DNA was twice as fast (t 1/2 = 12 hr) as that from the chromatin proteins (t 1/2 = 24 hr). Liver nucleoplasmic and chromatin proteins were separated by sodium dodecyl sulfate:polyacrylamide gel electrophoresis. No major differences were observed in the Coomassie Blue dye-binding patterns of control and AFB1-treated animals for at least 36 hr postdosing. Although no significant radiolabeled protein peaks were detected in the nucleoplasmic fraction, two major peaks, accounting for 50 to 60{\%} of the total activity applied to the gel, were observed at each time point in the chromatin protein fraction, with apparent molecular weights of 15,000 and 30,000. Approximately 5 to 10{\%} of the total nuclear-bound aflatoxin residues were associated with these proteins, which were identified as histones by their extraction in 0.25 N HCl and their fractionation patterns on polyacrylamide gel filtration columns and acid:urea gel electrophoresis. Specific activity measurements demonstrated that histone H1 was the major protein target for [3H]AFB1 residue binding with an adduction level 3 to 4 times higher than that for any other histone. A linear, dose-dependent relationship for the binding of [3H]AFB1 residues to DNA, histone H1, and the total histone population was noted over a 16-fold dose range (0.125 to 2.0 mg AFB1 per kg). Turnover rates of rat liver histones as a function of AFB1 exposure were determined by labeling the amino acids of histones by i.p. injection of sodium [14C]bicarbonate 22 hr prior to treatment with the toxin and sacrificing the animals up to 4 days following the dosage protocol. The half-life of histone H1 and the total histone population was identical (approximately 3.5 days) in both control and AFB1-treated rats. However, the rate of removal of [3H]AFB1 residues following either a 0.125- or a 1.0-mg/kg dose was 3 to 4 times faster (t 1/2 = approximately 1 day) than was the decrease in specific activity of the 14C-labeled histone backbone.",
author = "Groopman, {John Davis} and Busby, {W. F.} and Wogan, {G. N.}",
year = "1980",
language = "English (US)",
volume = "40",
pages = "4343--4351",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo

AU - Groopman, John Davis

AU - Busby, W. F.

AU - Wogan, G. N.

PY - 1980

Y1 - 1980

N2 - The distribution and retention of [3H]aflatoxin B1 (AFB1) residues in rat liver nuclear fractions were determined at 0.5, 2, 12, and 36 hr following administration of a single i.p. dose of [3H]AFB1 (1 mg/kg body weight). Approximately 85 to 90% of the nuclear-bound AFB1 was associated with chromatin 2 hr after aflatoxin treatment, with the remainder present in the nucleoplasmic fraction. Further fractionation of the chromatin showed that approximately 80% of the aflatoxin residues was bound to the DNA, 10% was removed by dialysis, and the remaining 10% was recoverable in the dialyzed chromatin protein fraction. The apparent rate of removal of aflatoxin residues from DNA was twice as fast (t 1/2 = 12 hr) as that from the chromatin proteins (t 1/2 = 24 hr). Liver nucleoplasmic and chromatin proteins were separated by sodium dodecyl sulfate:polyacrylamide gel electrophoresis. No major differences were observed in the Coomassie Blue dye-binding patterns of control and AFB1-treated animals for at least 36 hr postdosing. Although no significant radiolabeled protein peaks were detected in the nucleoplasmic fraction, two major peaks, accounting for 50 to 60% of the total activity applied to the gel, were observed at each time point in the chromatin protein fraction, with apparent molecular weights of 15,000 and 30,000. Approximately 5 to 10% of the total nuclear-bound aflatoxin residues were associated with these proteins, which were identified as histones by their extraction in 0.25 N HCl and their fractionation patterns on polyacrylamide gel filtration columns and acid:urea gel electrophoresis. Specific activity measurements demonstrated that histone H1 was the major protein target for [3H]AFB1 residue binding with an adduction level 3 to 4 times higher than that for any other histone. A linear, dose-dependent relationship for the binding of [3H]AFB1 residues to DNA, histone H1, and the total histone population was noted over a 16-fold dose range (0.125 to 2.0 mg AFB1 per kg). Turnover rates of rat liver histones as a function of AFB1 exposure were determined by labeling the amino acids of histones by i.p. injection of sodium [14C]bicarbonate 22 hr prior to treatment with the toxin and sacrificing the animals up to 4 days following the dosage protocol. The half-life of histone H1 and the total histone population was identical (approximately 3.5 days) in both control and AFB1-treated rats. However, the rate of removal of [3H]AFB1 residues following either a 0.125- or a 1.0-mg/kg dose was 3 to 4 times faster (t 1/2 = approximately 1 day) than was the decrease in specific activity of the 14C-labeled histone backbone.

AB - The distribution and retention of [3H]aflatoxin B1 (AFB1) residues in rat liver nuclear fractions were determined at 0.5, 2, 12, and 36 hr following administration of a single i.p. dose of [3H]AFB1 (1 mg/kg body weight). Approximately 85 to 90% of the nuclear-bound AFB1 was associated with chromatin 2 hr after aflatoxin treatment, with the remainder present in the nucleoplasmic fraction. Further fractionation of the chromatin showed that approximately 80% of the aflatoxin residues was bound to the DNA, 10% was removed by dialysis, and the remaining 10% was recoverable in the dialyzed chromatin protein fraction. The apparent rate of removal of aflatoxin residues from DNA was twice as fast (t 1/2 = 12 hr) as that from the chromatin proteins (t 1/2 = 24 hr). Liver nucleoplasmic and chromatin proteins were separated by sodium dodecyl sulfate:polyacrylamide gel electrophoresis. No major differences were observed in the Coomassie Blue dye-binding patterns of control and AFB1-treated animals for at least 36 hr postdosing. Although no significant radiolabeled protein peaks were detected in the nucleoplasmic fraction, two major peaks, accounting for 50 to 60% of the total activity applied to the gel, were observed at each time point in the chromatin protein fraction, with apparent molecular weights of 15,000 and 30,000. Approximately 5 to 10% of the total nuclear-bound aflatoxin residues were associated with these proteins, which were identified as histones by their extraction in 0.25 N HCl and their fractionation patterns on polyacrylamide gel filtration columns and acid:urea gel electrophoresis. Specific activity measurements demonstrated that histone H1 was the major protein target for [3H]AFB1 residue binding with an adduction level 3 to 4 times higher than that for any other histone. A linear, dose-dependent relationship for the binding of [3H]AFB1 residues to DNA, histone H1, and the total histone population was noted over a 16-fold dose range (0.125 to 2.0 mg AFB1 per kg). Turnover rates of rat liver histones as a function of AFB1 exposure were determined by labeling the amino acids of histones by i.p. injection of sodium [14C]bicarbonate 22 hr prior to treatment with the toxin and sacrificing the animals up to 4 days following the dosage protocol. The half-life of histone H1 and the total histone population was identical (approximately 3.5 days) in both control and AFB1-treated rats. However, the rate of removal of [3H]AFB1 residues following either a 0.125- or a 1.0-mg/kg dose was 3 to 4 times faster (t 1/2 = approximately 1 day) than was the decrease in specific activity of the 14C-labeled histone backbone.

UR - http://www.scopus.com/inward/record.url?scp=0019126444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019126444&partnerID=8YFLogxK

M3 - Article

C2 - 7438068

AN - SCOPUS:0019126444

VL - 40

SP - 4343

EP - 4351

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 12

ER -